Standard Chartered to Cut Over 15 of Corporate Functions Roles Amid Efficiency Drive NYTs Pips Puzzle Walkthrough Highlights Growing Role of Games in Subscription Strategy Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Drive Oil Prices to New Highs BJs Wholesale to Implement Major Store Changes Amid Consumer Spending Pullback PutinXi Talks Revive Stalled Power of Siberia 2 Pipeline Amid Iran War Disruptions Toshifumi Suzuki Architect of 7Elevens Global Expansion Dies at 93 GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly MBLY Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance LSF Q1 2026 Earnings Massive EPS Surprise Defies Expectations ORN Q1 2026 Earnings EPS Surprises Positively Revenue Uncertainty Weighs on Shares DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher MBINN Q1 2026 Earnings EPS Beats Estimates Depositary Shares Rise Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility Datadog DDOG Climbs 196 as Cloud Monitoring Demand Fuels Momentum Eaton Vance Short Duration Diversified Income Fund EVG Slides Marginally as Market Weighs Income Strategies SilverBox Corp V SBXE Holds Steady at 998 as Speculative Interest Remains Tame Alchemy Investments Acquisition Corp 1 Warrants ALCYW Hold Steady at 009 Support Amid Minimal Activity Exxon Mobil Board Proposals Draw Investor Scrutiny Amid Governance Focus AMTD Q4 2020 Earnings Massive EPS Beat Highlights Strong Operational Performance Fortress Biotech FBIO Gains 162 as Shares Approach Key Resistance at 297 Prediction Markets Signal Growing Odds of Fed Rate Hike by Mid2027 Berkshire Hathaways Latest Filing May Reveal Warren Buffetts Tiny Purchase Teased to CNBC Lowes Flags Caution as Consumers Shift Spending Patterns Upstart and LendingClub Weighing the Two AIPowered Lending Platforms in 2026 April Jobs Report Preview Labor Market Cools but Remains Resilient Economists Suggest Market Mood Nvidias Stock Movement Muted While IPO Activity Surges Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal